23andMe has reached a deal with pharma giant GlaxoSmithKline, giving the company access to their (your) genetic data to potentially develop new drugs. Did they just sell us all out? Not exactly.
mercredi 1 août 2018
Lifehacker
What You’re Really Agreeing to When You Sign Up for 23andMe Research
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire